Royal Bank Of Canada Omeros Corp Transaction History

Royal Bank Of Canada

  • $579 Billion
  • Q3 2025

A detailed history of Royal Bank Of Canada transactions in Omeros Corp stock. As of the latest transaction made, Royal Bank Of Canada holds 543,676 shares of OMER stock, worth $4.03 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
543,676
Previous 504,068 7.86%
Holding current value
$4.03 Million
Previous $1.51 Million 47.42%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
BUY
$3.06 - $4.48 $121,200 - $177,443
39,608 Added 7.86%
543,676 $2.23 Million
Q2 2025

Nov 21, 2025
BUY
$3.0 - $8.01 $14,235 - $38,007
4,745 Added 0.95%
504,068 $1.51 Million
Q2 2025

Aug 14, 2025
BUY
$3.0 - $8.01 $14,235 - $38,007
4,745 Added 0.95%
504,068 $1.51 Million
Q1 2025

Nov 21, 2025
SELL
$7.04 - $11.21 $312,245 - $497,197
-44,353 Reduced 8.16%
499,323 $4.1 Million
Q1 2025

May 15, 2025
SELL
$7.04 - $11.21 $5,082 - $8,093
-722 Reduced 0.14%
499,323 $4.1 Million
Q4 2024

Feb 14, 2025
BUY
$3.77 - $12.15 $11,551 - $37,227
3,064 Added 0.62%
500,045 $4.94 Million
Q3 2024

Nov 14, 2024
SELL
$3.54 - $5.47 $65,405 - $101,063
-18,476 Reduced 3.58%
496,981 $1.97 Million
Q2 2024

Aug 14, 2024
SELL
$3.04 - $4.23 $66,196 - $92,108
-21,775 Reduced 4.05%
515,457 $2.09 Million
Q1 2024

Nov 05, 2024
BUY
$2.88 - $4.89 $62,712 - $106,479
21,775 Added 4.22%
537,232 $1.85 Million
Q1 2024

May 15, 2024
BUY
$2.88 - $4.89 $81,480 - $138,347
28,292 Added 5.56%
537,232 $1.85 Million
Q4 2023

Feb 14, 2024
SELL
$1.08 - $3.63 $1.67 Million - $5.62 Million
-1,546,959 Reduced 75.24%
508,940 $1.66 Million
Q3 2023

Nov 14, 2023
BUY
$2.81 - $5.69 $4.15 Million - $8.41 Million
1,478,167 Added 255.86%
2,055,899 $6 Million
Q2 2023

Aug 14, 2023
BUY
$4.45 - $7.57 $8,900 - $15,140
2,000 Added 0.35%
577,732 $3.14 Million
Q1 2023

May 15, 2023
SELL
$2.48 - $5.22 $5,842 - $12,298
-2,356 Reduced 0.41%
575,732 $2.68 Million
Q4 2022

Feb 14, 2023
SELL
$1.75 - $3.96 $16,850 - $38,130
-9,629 Reduced 1.64%
578,088 $1.31 Million
Q3 2022

Nov 14, 2022
SELL
$3.09 - $7.46 $32,568 - $78,628
-10,540 Reduced 1.76%
587,717 $1.85 Million
Q2 2022

Aug 15, 2022
SELL
$1.92 - $6.28 $3,553 - $11,624
-1,851 Reduced 0.31%
598,257 $1.65 Million
Q1 2022

May 16, 2022
SELL
$5.07 - $7.2 $27,717 - $39,362
-5,467 Reduced 0.9%
600,108 $3.61 Million
Q4 2021

Feb 14, 2022
BUY
$5.67 - $8.54 $11,016 - $16,593
1,943 Added 0.32%
605,575 $3.89 Million
Q3 2021

Nov 15, 2021
SELL
$13.4 - $16.3 $202,929 - $246,847
-15,144 Reduced 2.45%
603,632 $8.32 Million
Q2 2021

Aug 16, 2021
BUY
$14.81 - $19.13 $9.16 Million - $11.8 Million
618,776 New
618,776 $9.18 Million

Others Institutions Holding OMER

# of Institutions
155
Shares Held
33.1M
Call Options Held
2.2M
Put Options Held
2.72M
View Full List

About OMEROS CORP

OMER Quotes by TradingView
  • Ticker OMER
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,730,000
  • Market Cap $465M
  • Description
  • Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...
More about OMER
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email